alloy was 40 ~ 50 nm, with a tube length of 300 nm. 
When testing the corrosion resistance of the 
nanotubed surface of c.p. Ti and Ti-5Cr-9Mo alloy in 
Hank‘s solution after heat treatment, the corrosion 
potential (Ecorr) increased and the corrosion current 
density (Icorr) reduced when compared with untreated 
specimens. This result shows that specimens with 
nanotubes can still maintain good corrosion 
resistance. XPS analysis results showed that the 
nanotubes on c.p. Ti are composed of TiO2 and on Ti-
5Cr-9Mo alloy are composed of TiO2, Cr2O3 and MoO2. 
FTIR analysis confirmed that the surface of the 
nanotubed c.p. Ti and Ti-5Cr-9Mo alloy can be 
successfully grafted with OMP peptide by covalent 
bonding. Biocompatibility results showed that 
grafting OMP peptide to nanotubed cp Ti and Ti-5Cr-
9Mo alloy produced the best cell growth activity. 
 
 
 
英文關鍵詞： titanium alloy, nano-tube, peptide, corrosion 
resistance, biocompatibility 
 
 2
中文摘要 
本研究選用 c.p. Ti和 Ti-5Cr-9Mo 合金為基材，首先利用陽極氧化方法合金表面形成奈米管柱，
接著在利用 RGD 胜肽於表面進行接枝，希望提升生物相容性。研究結果顯示 c.p.Ti和 Ti-5Cr-9Mo合
金於 0.3 M NaCl和 0.14 M NH4F 混合電解液中，以適當定電壓可形成均勻奈米管陣列，再經由 450
℃ 持溫 4小時熱處理，可得到銳鈦礦相之結晶結構，其中 c.p. Ti之奈米管內徑為 40~50 nm和管長為 
250 nm。Ti-5Cr-9Mo合金之奈米管內徑為 40~50 nm和管長為 300 nm。在人工模擬體液之耐蝕性方面，
表面具有二氧化鈦奈米管陣列的 c.p. Ti 與 Ti-5Cr-9Mo合金經過 450℃熱處理後，腐蝕電位(Ecorr)會增
加和腐蝕電流密度(Icorr)會降低，表示合金表面製作奈米管陣列，經過適當熱處理，仍可以維持良好之
耐蝕性。XPS 分析之結果顯示 c.p. Ti 經陽極氧處理後所形成的奈米管陣列，均由二氧化鈦化合物所組
成，鈦是以 Ti4+  形式存在。Ti-5Cr-9Mo 合金所形成的奈米管陣列，一部分由二氧化鈦化合物所組成，
另一部分分別由鉻和鉬的氧化物所組成。二氧化鈦奈米管陣列中之鈦是以 Ti4+  形式存在，而鉻與鉬
分別是以 Cr3+ 與 Mo4+ 存在。FTIR分析證實 c.p. Ti 與 Ti-5Cr-9Mo合金表面經陽極氧化處理後，再
利用浸泡共價鍵結合的方式可以成功接枝OMP胜肽。生物相容性結果證實有接枝 OMP 胜肽的 c.p. Ti 
與 Ti-5Cr-9Mo合金表現出最佳的細胞生長活性。 
 
關鍵詞：鈦合金、奈米管、耐蝕性、胜肽、生物相容性 
 
英文摘要 
In this study, cp Ti and Ti-5Cr-9Mo alloy were used as the substrates.  In order to enhance 
biocompatibility of the substrates, the nanotubes were fabricated by anodic oxidation and the RGD peptides 
were grafted on the surface. The corrosion resistance of the substrates with a nanotube surface was examined. 
The results show that the highly ordered nanotube oxide layers developed on the surface of c.p. Ti and 
Ti-5Cr-9Mo alloy in the 0.3 M NaCl and 0.14 M NH4F mixed solution at an appropriate electric potential for 
one hour. After being annealed at 450℃ for four hours, the nano-tubes transformed into a rutile crystal 
structure. The average inner diameter of the nanotubes formed on c.p. Ti was 40 ~ 50 nm, with a tube length 
of 250 nm. The average inner diameter of the nanotubes formed on Ti-5Cr-9Mo alloy was 40 ~ 50 nm, with a 
tube length of 300 nm. When testing the corrosion resistance of the nanotubed surface of c.p. Ti and 
Ti-5Cr-9Mo alloy in Hank's solution after heat treatment, the corrosion potential (Ecorr) increased and the 
corrosion current density (Icorr) reduced when compared with untreated specimens. This result shows that 
specimens with nanotubes can still maintain good corrosion resistance. XPS analysis results showed that the 
nanotubes on c.p. Ti are composed of TiO2 and on Ti-5Cr-9Mo alloy are composed of TiO2, Cr2O3 and MoO2. 
FTIR analysis confirmed that the surface of the nanotubed c.p. Ti and Ti-5Cr-9Mo alloy can be successfully 
grafted with OMP peptide by covalent bonding. Biocompatibility results showed that grafting OMP peptide to 
nanotubed cp Ti and Ti-5Cr-9Mo alloy produced the best cell growth activity. 
 
Keywords: titanium alloy, nano-tube, peptide, corrosion resistance, biocompatibility 
PDF created with pdfFactory Pro trial version www.pdffactory.com
 4
研究目的 
上述方法仍有缺點亟待改進如：接黏在金屬表面之蛋白質易於脫落且不穩定等；為此本計畫擬針
對 Ti-5Cr-9Mo 合金，利用最佳化表面生成 Ti-OH 基，採用生化表面處理，將 RGD 胜肽序列固定於
Ti-5Cr-9Mo 合金表面，希望藉由共價鍵結方式將 RGD 胜肽接枝於金屬表面，穩定結構不易脫落，以
達誘導細胞和組織生長。研究主要探討利用化學共價結合方式將 RGD固定於 Ti-5Cr-9Mo合金表面，
並分析MG-63類骨母細胞生長於此鈦金屬試片上之鈣化作用。 
研究方法 
將商業用純鈦(grade II)中加入鉻(純度 99.5%)合金元素，依合金設計配置重量百分比以真空電弧殼
式熔融機(1000 Miller Dimension, USA)熔融與鑄造成合金。先將元素成分置於熔煉用銅坩堝中，熔煉室
以高純度氬氣為保護氣體，使合金表面不易產生氧化，最後再將金屬液倒入鑄模中成型。將合金以慢
速切割機切成圓盤狀試片(直徑 12 mm)，之後以 SiC砂紙進行表面研磨。 
將試片置於 2％APTES（3-aminopropyltriethoxysilane）溶液中，再加入 RGD 胜肽（購自 Sigma
公司）溶液（50 nmol/50 ul）於鈦金屬表面進行固定化作用，利用二次水清洗試片即完成固定化作用；
將固定化後之試片置於室溫下乾燥，並加以保存。 
MG-63類骨母細胞株以 Dulbecco’s modified Eagle’s 培養基 (內含 10% fetal bovine serum) 培
養於 25T培養瓶並保持在 37℃，5% CO2之培養箱中。以 DMEM (+10% fetal bovine serum) 懸浮細胞後，
將骨母細胞植覆於金屬試片上，骨母細胞植入量為 l × l04 cells (經不同密度生長曲線)，經過培養、細
胞貼附後，以 SEM觀察細胞形態。 
分析細胞分裂的情形。在加入MTT四個小時後加入 SDS 500 ul。隔天經免疫酵素分析儀測定，於
590 nm 的波長讀取細胞之吸光值，並由其結果分析細胞活性。 
結果與討論 
圖 1(a)所示為 SEM觀察 Ti-5Cr-9Mo 合金試片表面形成奈米管之形態； Ti-5Cr-9Mo 合金在電壓
10 V，時間 60 min 進行陽極氧化處理，表面的奈米結構不平整，沒有形成二氧化鈦奈米管。當電壓從 
10V 提升到 11V 時，試片表面呈現多孔結構，合金並沒有完全的被孔蝕；再提升電壓至 12V，試片
表面呈現多孔結構，表面孔蝕的痕跡更明顯；當電壓提升至 13V 合金表面有奈米管的形態產生(圖 1
所示)，奈米管孔徑的大小約 40 nm~50 nm。圖 1(b)為 Ti-5Cr-9Mo 合金經陽極處理後之橫截面，奈米
管管長為 300 nm，二氧化鈦奈米管的長度不受陽極氧化電壓的影響，而是隨著陽極氧化的時間增加而
增長。 
       
 
 
 
 
 
      圖 1. SEM 觀察試片表面形成奈米管之形態(a)表面形態；(b)橫截面 
PDF created with pdfFactory Pro trial version www.pdffactory.com
 6
WST-1 分別分析 Ti-5Cr-9Mo合金的細胞活性，如圖 4所示，結果顯示第 4天和第 7天的細胞活性
看出 Ti-5Cr-9Mo合金接枝 OMP-Ⅲ 因子的吸光值，比其它試片條件的吸光值高出許多，證實經由多孔
處理並且接枝 OMP 胜肽最有利於細胞的生長。 
 
 
 
 
 
 
 
 
 
 
         圖 4. Ti-5Cr-9Mo 合金與 MG-63 骨母細胞共培養之 1、4、7天細胞活性分析 
 
結論 
(1) 試片在人工模擬體液之耐蝕性方面，表面具有二氧化鈦奈米管陣列的 c.p. Ti 與 Ti-5Cr-9Mo合金，
腐蝕電位會降低和腐蝕電流密度會增加，但是經過 450℃熱處理後，反而其腐蝕電位會增加和腐蝕電
流密度會降低，說明試片表面製作奈米管陣列，必須經過適當熱處理，以維持良好之耐蝕性。 
(2) XPS 分析之結果顯示 c.p. Ti 經陽極氧處理後所形成的奈米管陣列，均由二氧化鈦化合物所組成，
二氧化鈦奈米管陣列中之鈦是以 Ti4+  形式存在。Ti-5Cr-9Mo 合金經陽極氧處理後所形成的奈米管陣
列，一部分由二氧化鈦化合物所組成，另一部分分別由鉻和鉬的氧化物所組成。二氧化鈦奈米管陣列
中之鈦是以 Ti4+  形式存在，而鉻與鉬分別是以 Cr3+ 與 Mo4+ 存在。 
(3) 生物相容性方面，c.p. Ti、Ti-5Cr-9Mo 與 MG-63 骨母共培養證實有接枝 OMP 的 c.p. Ti 與 
Ti-5Cr-9Mo合金表現出最佳的細胞生長活性。 
 
參考文獻 
Ankem S, Greene SA, Recent developments in microstructure/property relationships of beta titanium alloys. 
Mater. Sci. Eng. A. 263:127-131, 1999. 
Donachie MJ, Titanium: A Technical Guid. ASM International, Metals. Park. OH: 31:28, 1989. 
Ho WF, Wu SC, Chang HH, Hsu HC, Structure and mechanical properties of Ti–5Cr based alloy with Mo 
addition, Materials Science and Engineering: C 30(6): 904-909, 2010. 
Long M, Rack HJ, Titanium alloys in total joint replacement - a materials science perspective. Biomaterials 
19(18):1621-1639, 1998. 
Niinomi M, Mechanical properties of biomedical titanium alloys. Mater. Sci. Engng. A. 243:231-236, 1998. 
Roessler S, Born S, Scharnweber D, et al Biomemitic coatings functionalized with adhesion peptides for 
PDF created with pdfFactory Pro trial version www.pdffactory.com
 8
 
 
國科會補助專題研究計畫成果報告自評表 
請就研究內容與原計畫相符程度、達成預期目標情況、研究成果之學術或應用價
值（簡要敘述成果所代表之意義、價值、影響或進一步發展之可能性）、是否適
合在學術期刊發表或申請專利、主要發現或其他有關價值等，作一綜合評估。 
1. 請就研究內容與原計畫相符程度、達成預期目標情況作一綜合評估 
□ ▓達成目標 
□ 未達成目標（請說明，以 100字為限） 
□ 實驗失敗 
□ 因故實驗中斷 
□ 其他原因 
說明： 
 
 
 
2. 研究成果在學術期刊發表或申請專利等情形： 
論文：□已發表 □未發表之文稿 ▓撰寫中 □無 
專利：□已獲得 □申請中 □無 
技轉：□已技轉 □洽談中 □無 
其他：（以 100字為限） 
 
 
 
附件二 
PDF created with pdfFactory Pro trial version www.pdffactory.com
國科會補助專題研究計畫項下出席國際學術會議心得報告 
                                    日期： 101 年 2 月 29日 
一、參加會議經過 
本年度獲國科會研究計畫 「高強度低彈性模數 Ti-5Cr-9Mo合金表面改質提升
生物相容性之研究 100-2221-E-166-007-」。於 101年 2月 18日、19日二天參加「第
25屆齒科鈦學會學術講演會」 （Proceedings the 25th  symposium in titanium in 
dentistry），並發表論文「Effects of Mo to Ti-5Cr alloy on corrosion and 
biocompatibility」。與會多位學者包括:久保田正廣日本大學生產工學部機械工學科教
授)和渡邊孝一(新瀉大學教授)對於本篇發表具有濃厚興趣，對於未來的研究方向有
正面之建議，幫助頗大。 
二、與會心得 
計畫編號 
100-2221-E-166-007-  
計畫名稱 高強度低彈性模數 Ti-5Cr-9Mo合金表面改質提升生物相容性之研究 
出國人員
姓名 
許學全 
服務機構
及職稱 
中臺科技大學教授 
會議時間 
 101年 2月 18
至 100年 2月 19 
會議地點 日本 
會議名稱 
(中文)第 25屆齒科鈦學會學術講演會 
(英文) Proceedings the 25th  symposium in titanium in dentistry 
發表論文
題目 
(中文) Mo添加 Ti-5Cr合金之耐蝕性和生物相容性 
(英文) Effects of Mo to Ti-5Cr alloy on corrosion and biocompatibility 
PDF created with pdfFactory Pro trial version www.pdffactory.com
Mo添加のTi-5Cr合金の耐食性と生体適合性 
¡許 学全1,2, 菊地 久二3,4, 黒谷 知子3, 方 立陞2, 黄 曉筠2, 何 文福5 
1中台科技大学牙体技術及材料系(〒40605台湾台中市北屯区部子里部子路666号) 
2中台科技大学医工及材料研究所(〒40605台湾台中市北屯区部子里部子路666号) 
3日本大学歯学部歯科理工教室(〒101-8310東京都千代田区神田駿河台1-8-13) 
   4日本大学歯学部総合歯科研究所生体工学研究部門(〒101-8310東京都千代田区神田駿河台1-8-13) 
5大葉大学材料科学与工程学系(〒51591台湾彰化県大村郷学府路168号) 
 
 
１．Introduction 
Titanium and its alloys are extensively used as 
biomedical implant materials because of their good 
mechanical properties. As the most widely used Ti 
alloy for medical implants, Ti-6Al-4V, does not 
satisfy the requirements - low elastic modulus close 
to that of cortical bone and good biocompatibility - 
for such use. Therefore, other titanium-based 
biomedical alloys with different alloying elements 
are currently the subject of intensive study1-3). This 
work was conducted to develop new as-cast Ti-
based alloys with biocompatible elements, i.e. 
chromium and molybdenum.  
 
２．Materials and methods 
Six Ti-5Cr-xMo (X = 1, 3, 5, 7, 9, 11 wt.%) 
alloys were prepared and their corrosion resistance 
and biocompatibility properties evaluated. The 
properties of these alloys were compared with those 
of commercially pure titanium (c.p. Ti) and Ti-6Al-
4V alloy. The experimental Ti-5Cr-xMo alloys 
were cast at argon atmosphere using a vacuum arc 
melting machine (Castmatic, Iwatani Corp., Japan). 
For the corrosion and biocompatibility experiments, 
the specimens were cut into disk 12 mm in diameter 
and 0.8 mm in thickness. Each specimen was 
grinded up to 1500 grit on wet SiC abrasive paper 
and polished with 0.3 μm alumina powder.  
During corrosion testing, the corrosion cell was 
connected to a potentiostat (Versa Stat TM II 
Potentiostat/Golvanostat Model 263A; Princeton 
Applied Research, NJ, USA) controlled by a 
personal computer with dedicated software 
(PowerSuit-2.56, Princeton Applied Research). 
Electrochemical tests were conducted in Hank’s 
solution. The open circuit potential (OCP) test was 
performed for a duration of 14400 s and the 
potentiodynamic polarization test was scanned form 
-1.5 V to 2 V at 1 mV/s. 
During the biocompatibility experiments, the 
osteoblast-like cell line MG-63 was cultured in 
Dulbecco’s minimum essential medium (DMEM) 
containing 10％ heat-inactivated charcoal dextran-
stripped fetal calf serum, and incubated at 37 ℃. 
The cells were cultured for 1 day, 4 days and 7 
days, respectively. The cell growth morphology 
was observed by scanning electron microscopy (S-
3000N, Hitachi, Japan). 
 
３．Results and discussion 
The OCP measurement indicates the changes in 
the corrosion potential of the specimens in Hank’s 
solution. The corrosion potential continually 
reached a stable potential after 14400 s of 
immersion. This tendency is in agreement with the 
result of the potentiodynamic polarization test. The 
OCP showed that the addition of Mo to Ti-5Cr 
elevates the final stable potential. Ti-5Cr-11Mo had 
the highest potential (-0.42 V), the potential of c.p. 
Ti was -058 V and Ti-6Al-4V had a potential of
-0.47 V. The dynamic polarization curve showed 
that Ti-5Cr-9Mo had the highest corrosion potential 
(Ecorr) at -0.85 V, while the corrosion potential for 
c.p. Ti was -1.16 V. By using a current density of 
0.25 V (I0.25V), it was shown that the current density 
of the Ti-5Cr-xMo alloys was lower than that of 
c.p. Ti and Ti-6Al-4V. Hence, the addition of Mo to 
Ti-5Cr has been shown to improve corrosion 
resistance. 
With regard to biocompatibility, the osteoblast-
like cell (MG-63) co-culture with Ti-5Cr-xMo 
alloys, the SEM observation and WST-1 assay 
indicate that Ti-5Cr-5Mo had the highest cell 
quantity and absorbance value, followed by Ti-5Cr-
3Mo. The ALP test showed that Ti-5Cr-3Mo had a 
more rapid cell differentiation than c.p. Ti, but no 
significant difference was noted when the alloy was 
compared with Ti-6Al-4V. 
 
References 
1) W. F. Ho, S. C. Wu, C. W. Lin, S. K. Hsu, H. C.
Hsu: J. Appl. Electrochem. 41:3, 337-43 (2011). 
2) W. F. Ho, S. C. Wu, H. H. Chang, H. C. Hsu:
Materials Science and Engineering: C 30: 6, 904-9 
(2010). 
3) S. C. Wu, W. F. Ho, C. W. Lin, H. Kikuchi, F. T.
Lin, H. C. Hsu: Dental Materials J. 30: 3,  368-73
(2011).  
 
 
P-2 
 
PDF created with pdfFactory Pro trial version www.pdffactory.com
100 年度專題研究計畫研究成果彙整表 
計畫主持人：許學全 計畫編號：100-2221-E-166-007- 
計畫名稱：高強度低彈性模數 Ti-5Cr-9Mo 合金表面改質提升生物相容性之研究 
量化 
成果項目 實際已達成
數（被接受
或已發表）
預期總達成
數(含實際已
達成數) 
本計畫實
際貢獻百
分比 
單位 
備 註 （ 質 化 說
明：如數個計畫
共同成果、成果
列 為 該 期 刊 之
封 面 故 事 ...
等） 
期刊論文 0 0 100%  
研究報告/技術報告 0 0 100%  
研討會論文 0 0 100% 
篇 
 
論文著作 
專書 0 0 100%   
申請中件數 0 0 100%  專利 已獲得件數 0 0 100% 件  
件數 0 0 100% 件  
技術移轉 
權利金 0 0 100% 千元  
碩士生 1 1 100%  
博士生 0 0 100%  
博士後研究員 0 0 100%  
國內 
參與計畫人力 
（本國籍） 
專任助理 0 0 100% 
人次 
 
期刊論文 0 0 100%  
研究報告/技術報告 0 0 100%  
研討會論文 1 1 100% 
篇 
 
論文著作 
專書 0 0 100% 章/本  
申請中件數 0 0 100%  專利 已獲得件數 0 0 100% 件  
件數 0 0 100% 件  
技術移轉 
權利金 0 0 100% 千元  
碩士生 2 2 100%  
博士生 0 0 100%  
博士後研究員 0 0 100%  
國外 
參與計畫人力 
（外國籍） 
專任助理 0 0 100% 
人次 
 
